TradeSun
$XBI
I think we’re getting closer to a buying window for small- and mid-cap biotech.
Pull up the five-year charts on $ALT, $GPCR, $AUTL, and $CABA. Several of these names are trading near the bottom of their five-year ranges.
September 21 is where the selloff starts to stand out to me. Treasury yields pushed higher in the days that followed. The 10-year hit its highest level since 2007, the 30-year reached levels last seen in 2004, and the 2-year climbed as well.
I think this sector is due for a rebound at some point. Take a look at the charts.
23

:format(webp)/https%3A%2F%2Fst-everywhere-cms-prod.s3.us-east-1.amazonaws.com%2Flarge_capricor_jpg_9f4f8ab098.webp)
:format(webp)/https%3A%2F%2Fst-everywhere-cms-prod.s3.us-east-1.amazonaws.com%2Flarge_Getty_Images_2195599761_jpg_ec0e618b8c.webp)
:format(webp)/https%3A%2F%2Fst-everywhere-cms-prod.s3.us-east-1.amazonaws.com%2Flarge_Getty_Images_2267825783_jpg_1b90bf709b.webp)